New developments in the complex and rapidly changing world of acute myeloid leukemia (AML) promise to improve health outcomes for people with the disease. They include: Advances in diagnostics ...
Recently recognized by the World Health Organization, acute myeloid leukemia (AML) with t(7;12)(q36;p13) has previously been associated with MNX1 and ETV6 signaling, although MNX1::ETV6 fusion ...
Dr. Eunice Wang shares the importance of staying informed about AML subtypes and genetic mutations like FMS-like tyrosine kinase 3 (FLT3), getting tested and engaging your caregiver team Imagine ...
The panel reached ≥97.8% consensus on AML management. The panel agreed to use international risk stratification categories for personalized treatment of AML. The presence of ≥10% blasts for recurrent ...
The Beat AML Master Trial found high remission rates and promising safety with triplet therapy in patients with acute myeloid leukemia (AML), according to Ashley Yocum, PhD. In part 2 of an interview ...
Editor’s note: Look for a follow-up story next week about how big data is advancing cancer research studies like this one. The first-ever comprehensive effort to characterize acute myeloid leukemia in ...
Initial findings from a multi-national open-label phase Ib study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response in up to 50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results